School of Medicine, New York Medical College, Valhalla, NY 10595, United States of America.
Department of Neurosurgery, Westchester Medical Center at New York Medical College, Valhalla, NY 10595, United States of America.
J Neurol Sci. 2022 Mar 15;434:120168. doi: 10.1016/j.jns.2022.120168. Epub 2022 Jan 26.
The safety and efficacy of intravenous thrombolysis (IVT) before endovascular thrombectomy (EVT) for large vessel occlusion stroke remains a highly contested and unanswered clinical question. We aim to characterize the clinical profile, complications, and discharge disposition of EVT patients treated with and without preceding IVT using a large, nationally-representative sample.
The National Inpatient Sample was queried from 2015 to 2018 to identify adult patients with anterior circulation stroke treated with EVT with and without preceding IVT. Multivariable logistic regression analysis and propensity-score matching were employed to assess adjusted associations with clinical endpoints and to address confounding by indication for IVT, respectively.
Among 48,525 patients identified, 40.7% (n = 19,735) received IVT prior to EVT. On unadjusted analysis, patients treated with IVT bridging therapy experienced higher rates of intracranial hemorrhage (26% vs. 24%, p = 0.003) and routine discharge to home with or without services (33% vs. 27%, p < 0.001), a lower frequency of thromboembolic complications (3% vs. 5%, p < 0.001), and lower rates of extended hospital stays (eLOS) (20% vs. 24%, p < 0.001). Multivariable logistic regression analysis adjusting for demographic and baseline clinical characteristics demonstrated independent associations of IVT bridging therapy with intracranial hemorrhage (aOR 1.28, 95% CI 1.15, 1.43; p < 0.001), thromboembolic complications (aOR 0.66, 95% CI 0.53, 0.83; p < 0.001), routine discharge (aOR 1.27, 95% CI 1.15, 1.40; p < 0.001), and eLOS (aOR 0.76, 95% CI 0.68, 0.85; p < 0.001). Sensitivity testing confirmed these findings.
Preceding IVT was associated with favorable functional outcomes following endovascular therapy. Prospective randomized clinical trials are warranted for further evaluation.
静脉溶栓(IVT)在前循环大血管闭塞性卒中血管内治疗(EVT)之前的安全性和疗效仍然是一个备受争议且尚未解决的临床问题。我们旨在使用大型全国代表性样本描述接受和不接受 IVT 桥接治疗的 EVT 患者的临床特征、并发症和出院情况。
从 2015 年至 2018 年,我们使用国家住院患者样本(National Inpatient Sample)确定了接受 EVT 治疗的前循环卒中成年患者,其中包括接受和不接受 IVT 桥接治疗的患者。多变量逻辑回归分析和倾向评分匹配分别用于评估与临床终点的调整关联,并分别解决 IVT 适应证的混杂因素。
在 48525 例患者中,40.7%(n=19735)在接受 EVT 治疗前接受了 IVT。在未调整分析中,接受 IVT 桥接治疗的患者颅内出血发生率较高(26% vs. 24%,p=0.003),常规出院回家并伴有或不伴有服务的比例较高(33% vs. 27%,p<0.001),血栓栓塞并发症发生率较低(3% vs. 5%,p<0.001),延长住院时间(eLOS)的发生率较低(20% vs. 24%,p<0.001)。调整人口统计学和基线临床特征的多变量逻辑回归分析表明,IVT 桥接治疗与颅内出血(优势比 1.28,95%置信区间 1.15,1.43;p<0.001)、血栓栓塞并发症(优势比 0.66,95%置信区间 0.53,0.83;p<0.001)、常规出院(优势比 1.27,95%置信区间 1.15,1.40;p<0.001)和 eLOS(优势比 0.76,95%置信区间 0.68,0.85;p<0.001)独立相关。敏感性测试证实了这些发现。
在前循环大血管闭塞性卒中血管内治疗之前接受 IVT 与血管内治疗后的良好功能结局相关。需要进行前瞻性随机临床试验以进一步评估。